Genesis Healthcare Inc
OTC:GENN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genesis Healthcare Inc
OTC:GENN
|
US |
|
Cados Corp
TSE:211A
|
JP |
|
D
|
Dine SAB de CV
BMV:DINEB
|
MX |
Balance Sheet
Balance Sheet Decomposition
Genesis Healthcare Inc
Genesis Healthcare Inc
Balance Sheet
Genesis Healthcare Inc
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
62
|
51
|
55
|
21
|
12
|
212
|
|
| Cash Equivalents |
62
|
51
|
55
|
21
|
12
|
212
|
|
| Short-Term Investments |
0
|
0
|
0
|
36
|
32
|
40
|
|
| Total Receivables |
789
|
832
|
724
|
623
|
568
|
427
|
|
| Accounts Receivables |
789
|
832
|
724
|
623
|
568
|
427
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
161
|
175
|
161
|
196
|
217
|
191
|
|
| Total Current Assets |
1 011
|
1 059
|
940
|
876
|
829
|
869
|
|
| PP&E Net |
4 085
|
3 765
|
3 414
|
2 888
|
3 399
|
2 728
|
|
| PP&E Gross |
4 085
|
3 765
|
3 414
|
2 888
|
3 399
|
2 728
|
|
| Accumulated Depreciation |
639
|
808
|
939
|
977
|
455
|
446
|
|
| Intangible Assets |
210
|
176
|
143
|
119
|
87
|
82
|
|
| Goodwill |
470
|
441
|
86
|
86
|
86
|
86
|
|
| Other Long-Term Assets |
283
|
339
|
206
|
296
|
261
|
297
|
|
| Other Assets |
470
|
441
|
86
|
86
|
86
|
86
|
|
| Total Assets |
6 060
N/A
|
5 779
-5%
|
4 788
-17%
|
4 264
-11%
|
4 662
+9%
|
4 062
-13%
|
|
| Liabilities | |||||||
| Accounts Payable |
234
|
259
|
286
|
235
|
238
|
211
|
|
| Accrued Liabilities |
383
|
397
|
401
|
401
|
521
|
2 571
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
14
|
26
|
29
|
125
|
165
|
909
|
|
| Other Current Liabilities |
168
|
175
|
183
|
152
|
147
|
154
|
|
| Total Current Liabilities |
799
|
858
|
899
|
912
|
1 071
|
3 845
|
|
| Long-Term Debt |
2 240
|
2 144
|
2 076
|
2 051
|
1 490
|
670
|
|
| Deferred Income Tax |
15
|
22
|
8
|
6
|
5
|
5
|
|
| Minority Interest |
183
|
240
|
596
|
705
|
322
|
342
|
|
| Other Liabilities |
3 626
|
3 486
|
3 486
|
3 339
|
3 178
|
705
|
|
| Total Liabilities |
6 496
N/A
|
6 270
-3%
|
5 872
-6%
|
5 603
-5%
|
5 423
-3%
|
4 882
-10%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
732
|
796
|
1 375
|
1 610
|
1 010
|
1 069
|
|
| Additional Paid In Capital |
295
|
305
|
291
|
270
|
249
|
247
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
436
N/A
|
490
-12%
|
1 084
-121%
|
1 340
-24%
|
761
+43%
|
820
-8%
|
|
| Total Liabilities & Equity |
6 060
N/A
|
5 779
-5%
|
4 788
-17%
|
4 264
-11%
|
4 662
+9%
|
4 062
-13%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
154
|
155
|
159
|
162
|
165
|
167
|
|